165 results
Page 4 of 9
424B5
0a7kn297hlh8 kxvot
10 Jun 20
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
0fe5e9
9 Jun 20
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:21pm
424B5
s08kgd
8 Jun 20
Prospectus supplement for primary offering
4:11pm
S-8
48ssx7ndho19 bl5
2 Mar 20
Registration of securities for employees
5:04pm
8-K
EX-99.1
d258wag2s2 cvof
2 Mar 20
Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook
4:01pm
8-K
EX-99.1
57jojk8a gum4fbmao
5 Nov 19
Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-1.1
rjj k8lpi8
12 Sep 19
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:30pm
424B5
7j3z9o9gi ptr4c0
12 Sep 19
Prospectus supplement for primary offering
9:25pm
424B5
4amr4zj0ft 8n
11 Sep 19
Prospectus supplement for primary offering
4:08pm